Bio-Rad Labs Financial Statements
Bio-Rad Labs Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Bio-Rad Labs Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 1,461.1 | 1,273.9 | 1,181.0 |
| Gross Profit ($ mil.) | 791.4 | 712.5 | 646.5 |
| Operating Income ($ mil.) | 135.2 | 146.1 | 124.5 |
| Total Net Income ($ mil.) | 93.0 | 103.3 | 81.6 |
| Diluted EPS (Net Income) | 3.41 | 3.83 | 3.06 |
Bio-Rad Labs Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 422.2 | 459.7 | 339.7 |
| Gross Profit ($ mil.) | 226.9 | 233.6 | 188.4 |
| Operating Income ($ mil.) | 49.7 | 23.1 | 37.5 |
| Total Net Income ($ mil.) | 26.5 | 12.4 | 28.0 |
| Diluted EPS (Net Income) | 0.96 | 0.45 | (191.04) |
Bio-Rad Labs Stock Quote & Chart
10/13/08 14:49:48 EST •
AMEX •
87.54
•
 -0.3600
•
-0.4096 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Bio-Rad Labs Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 1.49 | 2.19 | 1.56 |
| Price/Earnings Ratio | 30.36 | 22.29 | 15.82 |
| Price/Book Ratio | 2.14 | 2.28 | 1.52 |
| Price/Cash Flow Ratio | 11.48 | 15.76 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Bio-Rad Labs Financial Ratios
Bio-Rad Labs Competitive Intelligence
| Abbott Labs | Invitrogen | Roche Diagnostics | |
|---|---|---|---|
| Annual Sales ($ mil.) | 25,914.2 | 1,281.8 | 215.1 |
| Employees | 68,000 | 4,300 | 2,000 |
| Market Cap ($ mil.) | 90,488.8 | 3,991.3 | -- |
Competitive Landscape
